05/16/2024
8:13 PM | Atara Biotherapeutics (Subject)
Henrich Jill (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
8:13 PM | Atara Biotherapeutics (Subject)
Hyllengren Eric J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
8:14 PM | Atara Biotherapeutics (Subject)
Murugan Amar (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
8:14 PM | Atara Biotherapeutics (Subject)
Nguyen AnhCo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
8:15 PM | Atara Biotherapeutics (Subject)
Touchon Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
7:55 PM | Atara Biotherapeutics (Subject)
Nguyen AnhCo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/26/2024
3:20 PM | Atara Biotherapeutics (Filer)
| Form DEFA14A | |
The Worst is Yet to Come… (Ad) Millions of Unsuspecting Americans Could be Wiped Out…
Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly. Click here to stream this controversial exposé now. |
04/26/2024
3:15 PM | Atara Biotherapeutics (Filer)
| Form DEF 14A | |
04/12/2024
3:15 PM | Atara Biotherapeutics (Filer)
Atara Biotherapeutics (Filer)
| Form PRE 14A | |
04/02/2024
5:11 PM | Atara Biotherapeutics (Issuer)
MALLIK AMEET (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:12 PM | Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:12 PM | Atara Biotherapeutics (Issuer)
Roncarolo Maria Grazia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:12 PM | Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:13 PM | Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
7:40 AM | Atara Biotherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/28/2024
7:35 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
5:18 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:18 PM | Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:19 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:16 PM | Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:17 PM | Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
7:17 PM | Atara Biotherapeutics (Subject)
Murugan Amar (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
7:18 PM | Atara Biotherapeutics (Subject)
Hyllengren Eric J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
7:19 PM | Atara Biotherapeutics (Subject)
Henrich Jill (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
7:21 PM | Atara Biotherapeutics (Subject)
Touchon Pascal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
7:13 PM | Atara Biotherapeutics (Subject)
Nguyen Tran (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2024
3:45 PM | Atara Biotherapeutics (Subject)
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
| Form SC 13G/A | |
01/22/2024
12:58 PM | Atara Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/09/2024
3:40 PM | Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:40 PM | Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:40 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:40 PM | Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:41 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
3:28 PM | Atara Biotherapeutics (Filer)
| Form 424B5 | |
01/09/2024
3:22 PM | Atara Biotherapeutics (Subject)
BAUPOST GROUP LLC/MA (Filed by)
| Form SC 13G/A | |
01/08/2024
7:11 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2023
3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
1:45 PM | Atara Biotherapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
| Form SC 13G/A | |
11/20/2023
4:31 PM | Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad) For over four decades, Louis Navellier has found the very best tech stocks...
Before the rest of the market. Click for his six specific AI stock in the crosshairs |
11/20/2023
4:31 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
4:29 PM | Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
4:29 PM | Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
4:30 PM | Atara Biotherapeutics (Issuer)
Joshi Manher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
4:30 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
3:31 PM | Atara Biotherapeutics (Filer)
| Form 424B3 | |
11/14/2023
5:27 PM | Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
5:29 PM | Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
11:15 PM | Atara Biotherapeutics (Filer)
| Form EFFECT | |
11/08/2023
8:16 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2023
4:25 PM | Atara Biotherapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/01/2023
7:35 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2023
7:40 AM | Atara Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/18/2023
5:25 PM | Atara Biotherapeutics (Issuer)
Henrich Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
5:25 PM | Atara Biotherapeutics (Issuer)
Joshi Manher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
5:25 PM | Atara Biotherapeutics (Issuer)
Nguyen AnhCo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
5:25 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
5:25 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
5:25 PM | Atara Biotherapeutics (Issuer)
Hyllengren Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
3:15 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
7:06 PM | Atara Biotherapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:08 PM | Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:09 PM | Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:09 PM | Atara Biotherapeutics (Issuer)
MALLIK AMEET (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:09 PM | Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:09 PM | Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
6:09 PM | Atara Biotherapeutics (Issuer)
Roncarolo Maria Grazia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
